object
assess
whether
increas
daili
intak
vitamin
improv
serum
vitamin
level
serv
primari
prevent
respiratori
morbid
late
prematur
infant
method
random
doubleblind
clinic
trial
includ
preterm
infant
born
week
gestat
may
januari
control
group
receiv
iu
cholecalciferol
daili
compar
iu
daili
intervent
group
measur
level
oh
vitamin
birth
cord
blood
month
month
follow
respiratori
morbid
group
result
fifti
subject
recruit
studi
period
subject
group
median
oh
vitamin
level
control
group
vs
intervent
group
vs
nmoll
pvalu
birth
vs
nmoll
pvalu
month
vs
nmoll
pvalu
month
age
regard
respiratori
morbid
intervent
group
significantli
lower
vitamin
level
vs
pvalu
respiratori
diseas
followup
year
group
similar
rate
emerg
depart
visit
respiratori
symptom
number
reliev
consum
conclus
doubl
daili
intak
vitamin
first
year
life
increas
serum
level
compar
control
group
found
revers
associ
serum
vitamin
level
number
respiratori
diseas
prematur
infant
first
year
life
background
primari
immunodefici
pid
accompani
recurr
respiratori
infect
thought
devast
effect
pulmonari
function
major
aim
studi
investig
relationship
chest
comput
tomographi
ct
scan
morpholog
bronchiectasi
clinic
sever
dyspnea
deterior
pulmonari
function
paramet
method
children
diagnos
pid
tertiari
pediatr
refer
center
northern
taiwan
enrol
retrospect
review
demograph
clinic
data
includ
age
sex
age
diagnosi
pid
followup
period
chest
ct
imag
modifi
reiff
score
pulmonari
function
test
pft
paramet
qualiti
life
questionnair
mmrc
dyspnea
scale
collect
analyz
spearman
correl
use
correl
continu
variabl
statist
analys
perform
use
spss
softwar
version
ny
usa
result
total
children
pid
enrol
among
latter
patient
diagnos
bronchiectasi
base
chest
ct
scan
modifi
reiff
score
chest
ct
scan
neg
correl
predict
spearman
r
p
n
ratio
spearman
r
p
n
signific
neg
correl
found
mmrc
dyspnea
scale
predict
spearman
r
p
n
fvc
predict
spearman
r
p
n
contrast
mmrc
dyspnea
scale
posit
correl
rv
predict
spearman
r
p
n
rv
tlc
spearman
r
p
n
furthermor
durat
followup
period
found
significantli
neg
associ
fvc
predict
spearman
r
p
n
conclus
pediatr
patient
primari
immunodefici
chest
ct
scan
appear
good
tool
diagnosi
bronchiectasi
also
degre
pulmonari
function
impair
analysi
reveal
qualiti
life
impair
thse
patient
could
particularli
due
airflow
obstruct
air
trap
relat
bronchiectasi
object
earli
diagnosi
intervent
bronchial
asthma
children
import
although
clinic
method
object
evalu
bronchial
reaction
infant
young
children
avail
breath
sound
paramet
suggest
biomark
airway
narrow
children
use
commerci
avail
breath
sound
analyz
characterist
airway
condit
investig
infant
risk
factor
asthma
develop
method
total
infant
mean
age
month
rang
month
includ
present
studi
breath
sound
paramet
frequenc
limit
power
spectrum
rolloff
hz
slope
spectrum
curv
indic
total
area
curv
dbm
data
ratio
power
frequenc
highest
frequenc
power
spectrum
evalu
use
atsdld
base
origin
japanes
questionnair
examin
characterist
airway
condit
infant
result
altogeth
infant
histori
acut
respiratori
infect
analyz
slope
infant
posit
result
allergi
atop
dermat
significantli
increas
infant
neg
result
conclus
result
show
breath
sound
infant
risk
factor
asthma
develop
reveal
residu
airway
chang
even
healthi
state
breath
sound
analysi
may
use
assess
airway
infant
asthma
develop
introduct
obes
asthma
common
disord
preval
increas
recent
decad
studi
aim
recogn
correl
bodi
mass
index
bmi
clinic
present
durat
hospit
children
adolesc
diagnos
asthma
admit
tertiari
govern
hospit
gener
object
determin
correl
bmi
number
symptom
clinic
present
durat
hospit
among
children
age
year
old
admit
diagnosi
asthma
design
crosssect
analysi
subject
patient
year
old
admit
diagnosi
asthma
june
march
comorbid
pneumonia
cardiac
diseas
tuberculosi
demis
exclud
methodolog
weight
height
measur
upon
admiss
plot
appropri
center
diseas
control
cdc
bmiforag
growth
chart
includ
patient
subject
classifi
accord
bodi
mass
index
obes
overweight
normalhealthi
weight
underweight
symptom
sign
relat
asthma
record
upon
admiss
date
discharg
determin
medic
record
durat
hospit
day
comput
statist
analysi
spss
version
window
use
descript
statist
gener
variabl
nomin
data
frequenc
percentag
comput
numer
data
mean
sd
gener
point
interv
estim
odd
ratio
also
comput
analysi
differ
variabl
perform
use
anova
chisquar
test
pearson
correl
analysi
result
total
patient
includ
mean
age
year
equal
sex
distribut
major
healthi
weight
among
symptom
studi
significantli
higher
proport
p
valu
subject
short
breath
among
obes
underweight
group
higher
proport
subject
p
valu
higher
number
asthma
symptom
note
among
obes
underweight
group
significantli
posit
correl
coeffici
p
valu
bmi
number
symptom
p
valu
bmi
durat
hospit
also
note
conclus
result
studi
show
signific
correl
bmi
day
hospit
number
symptom
posit
correl
note
increas
bmi
hospit
day
number
symptom
also
increas
vice
versa
significantli
higher
proport
obes
overweight
underweight
children
asthma
present
short
breath
introduct
protract
bacteri
bronchiti
pbb
character
isol
chronic
wet
product
cough
without
sign
anoth
caus
usual
respond
week
appropri
oral
antibiot
cover
common
bacteria
respiratori
tract
haemophilu
influenza
streptococcu
pneumonia
manag
patient
fail
respond
initi
abstract
treatment
present
pbbextend
recurr
pbb
potenti
associ
develop
bronchiectasi
remain
controversi
aim
purpos
studi
evalu
effici
toler
long
durat
treatment
low
dose
azithromycin
pbbextend
method
regist
establish
includ
patient
age
year
underw
bronchoscopi
queen
fabiola
children
univers
hospit
januari
decemb
chronic
cough
treat
low
dose
azithromycin
minimum
month
pbbextend
result
respons
rate
cohort
higher
median
treatment
durat
month
less
patient
experienc
recurr
pbb
within
month
stop
treatment
side
effect
record
multipl
hospit
respiratori
infect
appear
factor
associ
treatment
failur
studi
suggest
azithromycin
may
effect
better
toler
altern
prolong
classic
antibiot
therapi
treatment
pbbextend
along
necess
confirm
result
random
protocol
background
bronchial
asthma
common
import
chronic
diseas
children
throughout
world
take
measur
preval
childhood
asthma
mani
research
survey
actual
status
childhood
asthma
develop
countri
howev
asiapacif
develop
countri
includ
mongolia
survey
never
suffici
conduct
date
thought
survey
though
perform
provid
import
meaning
inform
even
take
measur
prevent
prevail
bronchial
asthma
children
mongolia
countri
similar
status
asthma
preval
patient
background
inform
mongolian
children
age
live
ulaanbaatar
examin
use
written
questionnair
modifi
parent
prepar
intern
studi
asthma
allergi
childhood
isaac
estim
preval
asthma
mongolian
children
follow
risk
factor
found
relat
asthma
allerg
rhiniti
symptom
mother
smoke
histori
sever
respiratori
infect
asthma
preval
mongolian
children
higher
world
asia
pacif
countri
report
isaac
higher
preval
probabl
attribut
household
smoke
especi
mother
draftfre
hous
design
cold
area
well
sever
airpollut
due
rapid
industri
urban
mongolia
smoke
prohibit
mother
includ
famili
member
reduct
exposur
air
pollut
urgent
need
prevent
develop
childhood
asthma
background
asthma
children
year
old
difficult
diagnos
clinic
present
asthma
vari
age
test
diagnos
asthma
certainti
young
children
thu
clinician
left
tri
defin
differ
asthma
phenotyp
base
clinic
characterist
patient
method
diagnosi
asthma
definit
clinic
phenotyp
base
patient
histori
diagnost
workup
treatment
respons
follow
practal
gina
guidelin
result
children
year
old
diagnos
classifi
accord
asthma
clinic
phenotyp
male
femal
malefemal
ratio
children
year
age
children
year
age
children
classifi
virusinduc
asthma
child
exerciseinduc
asthma
children
allerg
asthma
specif
allerg
trigger
could
identifi
children
allerg
asthma
virusinduc
asthma
common
children
year
age
allerg
asthma
common
children
fromtwo
year
age
p
allerg
asthma
common
male
virusinduc
asthma
common
femal
p
statist
signific
differ
famili
histori
regard
allergi
increas
eosinophil
virusinduc
allerg
phenotyp
fever
crepit
common
virusinduc
asthma
allerg
asthma
clinic
sign
symptom
differ
group
viru
asthma
allerg
asthma
percentag
hospit
children
timesyear
allerg
asthma
group
higher
viru
asthma
statist
signific
differ
p
percentag
children
miss
school
asthma
day
moreyear
allerg
asthma
group
higher
virusinduc
asthma
group
statist
signific
differ
p
percentag
children
parent
leav
work
abstract
care
asthma
day
year
higher
virusinduc
asthma
statist
signific
differ
p
conclus
viral
asthma
common
children
year
old
allerg
asthma
common
children
fromtwo
year
old
histori
allerg
diseas
fever
crepit
common
viral
asthma
allerg
asthma
affect
qualiti
life
children
viral
asthma
background
complianc
major
compon
success
medic
treatment
howev
noncompli
remain
barrier
effect
deliveri
healthcar
worldwid
method
twenti
healthcar
facil
secondari
tertiari
hospit
belong
korean
academi
pediatr
allergi
respiratori
diseas
kapard
particip
questionnair
given
patient
current
receiv
treatment
form
inhal
oral
transderm
patch
mild
moder
asthma
result
total
patient
respond
questionnair
mean
age
year
rang
year
help
caregiv
percentag
patient
answer
take
prescrib
inhal
user
oral
medic
user
transderm
user
transderm
patch
user
significantli
greater
complianc
compar
two
group
p
inhal
user
oral
medic
user
transderm
patch
user
felt
medic
deliveri
system
easi
easi
use
p
method
administr
deem
difficult
part
treatment
regimen
follow
patient
prefer
oncedaili
administr
ie
frequenc
administr
conclus
asthma
medic
complianc
young
children
found
better
transderm
patch
group
may
due
requir
fewer
dose
easi
follow
instruct
complianc
point
view
transderm
patch
seem
use
longterm
asthma
control
children
compar
oral
inhal
medicin
asthma
one
common
chronic
inflammatori
diseas
peopl
asthma
sensit
airway
react
trigger
caus
mucosa
swell
airway
narrow
incid
asthma
increas
everi
year
increasingli
research
asthma
therapi
probiot
one
probiot
microorgan
provid
health
benefit
host
regul
microbi
balanc
intestin
control
immun
microenviron
allevi
condit
allergi
inflamm
studi
use
dermatophagoid
pteronyssinu
der
p
induc
femal
balbc
mice
allerg
reaction
mice
receiv
intraperiton
der
p
sensit
day
day
intranas
der
p
sensit
day
anim
asthma
model
establish
addit
der
psensit
mice
randomli
assign
two
group
one
fed
lgg
lactobacillu
rhamnosu
gg
day
test
prophylact
effect
asthma
group
fed
day
test
treatment
effect
asthma
normal
control
group
consist
nonsensit
mice
receiv
normal
salin
rather
der
p
accord
result
lgg
treatment
group
whether
der
psensit
suppress
airway
inflamm
abstract
airway
hyperrespons
decreas
ige
cytokin
rais
conclus
oral
lgg
prevent
treat
der
psensit
airway
inflammatori
reaction
therefor
oral
lgg
may
role
allerg
airway
diseas
prevent
treatment
background
studi
examin
relationship
dyspnea
percept
eosinophil
airway
inflamm
asthmat
children
object
test
hypothesi
eosinophil
airway
inflamm
associ
poor
percept
airway
obstruct
method
two
hundr
seventeen
asthmat
children
median
age
evalu
use
acetylcholin
chlorid
ach
challeng
test
feno
examin
ach
challeng
test
bhr
assess
provoc
concentr
ach
caus
decreas
forc
expiratori
volum
second
percept
dyspnea
score
use
modifi
borg
scale
dose
ach
dyspnea
threshold
defin
point
borg
scale
score
becam
higher
evalu
dyspnea
percept
score
decreas
rel
baselin
drop
dyspnea
threshold
drop
result
neg
correl
feno
r
p
posit
r
p
drop
neg
correl
r
p
feno
studi
nearfat
group
account
month
year
age
group
account
femalemal
sixtyon
percent
children
minh
citi
admiss
icu
increas
recent
dyspnea
chief
complaint
account
cough
wheez
dyspnea
essenti
symptom
fiftlyon
percent
histori
asthma
prevent
medic
ownership
record
case
rate
impair
conscious
ph
mm
hg
chest
xray
show
hyperinfl
infiltr
atelectasi
time
treatment
day
day
icu
day
ten
children
intub
receiv
ncpap
children
older
year
given
children
given
diaphyllin
children
given
salbutamol
children
given
adrenalin
subcutan
intub
patient
receiv
pressur
control
ventil
inspiratori
pressur
achiev
tidal
volum
approxim
mean
peep
approxim
ie
conclus
appropri
treatment
first
crucial
lower
number
children
intub
mechan
ventil
still
remain
last
recours
treatment
near
fatal
exacerb
asthma
diaphyllin
salbutamol
peanut
brazil
nut
sensit
profil
among
asthmat
patient
southern
taiwan
data
import
asian
popul
relev
childhood
lung
function
also
unknown
crosssect
studi
investig
associ
wheez
ill
lung
function
preschool
children
hong
kong
method
chines
children
younger
year
age
recruit
randomli
select
nurseri
kindergarten
throughout
hong
kong
demograph
earlylif
exposur
allergi
phenotyp
preschool
children
record
valid
modifi
isaac
questionnair
children
underw
incent
spirometri
measur
forc
expiratori
indic
buccal
swab
collect
dna
extract
tag
singlenucleotid
polymorph
snp
determin
taqman
genotyp
assay
genotyp
haplotyp
associ
snp
wheez
lung
function
trait
analyz
multivari
regress
rpackag
haplostat
respect
result
mean
sd
age
total
children
year
fortyon
percent
domest
exposur
cigarett
smoke
wherea
wheez
ever
current
wheez
respect
current
wheez
associ
respect
odd
ratio
or
two
snp
also
associ
frequenc
wheez
ill
past
month
or
p
p
current
wheez
also
associ
gac
haplotyp
p
two
snp
associ
fvc
ggg
haplotyp
associ
develop
valid
adher
questionnair
adolesc
asthma
control
inhal
corticosteroid
asthma
ic
multipl
hospit
clinic
japan
adher
ic
medic
separ
evalu
confidenti
question
ask
frequenc
forget
take
medicin
nonmed
studi
staff
best
model
predict
adher
form
multivari
logist
analysi
valid
model
perform
use
answer
question
separ
group
icstreat
asthma
patient
age
result
respons
adolesc
use
develop
data
set
separ
adolesc
use
valid
data
set
logist
model
select
develop
data
set
show
good
statist
fit
well
discrimin
poor
adher
auc
develop
valid
dataset
respect
probabl
adher
calcul
propens
score
logist
regress
model
name
pediatr
asthma
adher
questionnair
paaq
score
paaq
score
physician
rate
adher
differ
significantli
hypothet
direct
paaq
may
use
tool
evalu
adher
adolesc
icstreat
asthma
effect
longterm
inhal
corticosteroid
therapi
adren
suppress
growth
bone
health
children
asthma
year
diagnos
asthma
inhal
corticosteroid
therapi
month
includ
case
children
oral
steroid
exacerb
week
studi
asthma
chronic
ill
children
year
old
avoid
confound
effect
pubert
growth
acceler
seen
age
exclud
comparison
group
consist
agematch
children
asthma
ic
height
assess
accord
mid
parent
height
mph
serum
calcium
alkalin
phosphatas
vitamin
level
assay
group
low
dose
short
synacthen
test
perform
case
serum
cortisol
minut
test
perform
assess
hpa
axi
function
peak
cortisol
level
minut
consid
pass
test
exclud
adren
suppress
averag
daili
dose
ic
categor
low
medium
high
accord
publish
literatur
result
associ
longterm
ic
growth
chi
squar
valu
p
calcium
level
p
statist
signific
signific
associ
found
longterm
inhal
corticosteroid
therapi
alp
level
p
although
interquartil
rang
serum
alp
group
within
normal
rang
age
statist
signific
differ
vitamin
level
group
p
although
vitamin
level
defici
case
control
nmoll
interestingli
suppress
cortisol
level
seen
case
cumul
dose
ic
case
low
medium
high
children
respect
result
total
antibiot
use
appear
decreas
year
followup
special
asthma
clinic
overal
use
p
use
amoxycillin
clavulan
p
statist
signific
use
amoxycillin
cephalosporin
macrolid
also
found
reduc
statist
signific
reduct
also
found
use
antihistamin
p
term
qualiti
life
statist
signific
improv
found
worri
domain
asthma
children
p
parent
p
well
impact
domain
parent
p
method
prospect
cross
section
studi
enrol
consecut
children
year
age
poorli
control
asthma
partli
control
uncontrol
per
gina
guidelin
juli
march
exclud
children
cystic
fibrosi
enrol
children
investig
abpa
includ
total
ige
aspergillusspecif
ige
aspergillusspecif
igg
skin
prick
test
aspergillu
serum
precipitin
absolut
eosinophil
count
aec
chest
xray
chest
ct
select
patient
abpa
diagnos
per
recent
criteria
follow
criteria
fulfil
total
ige
iuml
posit
skin
prick
test
spt
aspergillu
aspergillusspecif
ige
kual
least
two
follow
three
presenc
precipit
antibodi
aspergillusspecif
igg
mgl
chest
radiolog
suggest
abpa
total
eosinophil
count
data
analyz
use
stata
use
receiv
oper
characterist
roc
curv
along
area
curv
auc
determin
util
variou
paramet
differenti
children
abpa
without
determin
best
cutoff
youden
index
use
sensit
specif
result
includ
asthmat
children
male
femal
mean
sd
age
year
preval
abpa
ci
among
baselin
characterist
includ
spirometri
includ
children
presenc
brownish
sputum
abstract
greater
abpa
children
among
diagnost
criteria
significantli
differ
children
abpa
without
abpa
except
aspergillusspecif
igg
posit
spt
auc
ci
roc
shown
figur
differ
auc
total
ige
aspergillusspecif
ige
vs
aspergillusspecif
igg
signific
sensit
specif
total
ige
iuml
aspergillusspecif
ige
kual
aec
aspergillusspecif
igg
mgl
cutoff
defin
diagnost
criteria
respect
best
cutoff
valu
per
youd
index
total
ige
aspergillusspecif
ige
aec
aspergillusspecif
igg
iuml
kual
mgl
respect
correspond
sensit
specif
respect
conclus
aspergillusspecif
ige
level
best
discrimin
valu
follow
total
ige
aec
aspergillusspecif
igg
abpa
asthmat
children
current
propos
cutoff
valu
may
appropri
children
reflect
concret
propos
action
need
develop
childhoodspecif
diagnost
criteria
abpa
method
oneyear
retrospect
studi
conduct
pediatr
intens
care
unit
picu
compar
intervent
failur
rate
three
differ
noninvas
respiratori
support
modal
bilevel
posit
airway
pressur
bipap
continu
posit
airway
pressur
cpap
hfnc
infant
young
children
age
month
year
admit
diagnosi
bronchiol
sampl
size
patient
collect
median
age
month
children
requir
hfnc
older
mean
month
children
requir
bipap
month
mean
age
children
requir
cpap
month
result
hfnc
carri
higher
failur
rate
comparison
two
respiratori
support
modal
hfnc
vs
zero
cpap
bipap
p
among
patient
fail
hfnc
success
shift
bipap
wean
later
intub
need
mechan
ventil
hand
patient
fail
bipap
intub
mechan
ventil
differ
found
three
group
term
gender
caus
viru
respiratori
complic
mortal
report
three
group
bipap
group
oxygen
requir
significantli
reduc
hour
start
intervent
afterward
comparison
hfnc
group
p
although
statist
signific
cpap
group
differ
observ
length
picu
stay
hospit
stay
three
group
observ
associ
caus
viru
es
number
er
pulmonolog
clinic
visit
wheez
recurr
bronchodil
use
discharg
hospit
ba
group
found
viru
infect
predominantli
adenoviru
follow
rv
rsv
case
streptococcu
pneumonia
confirm
throat
swab
vs
isol
moraxella
catarrhali
bacteria
isol
ba
group
cwc
group
found
viral
infect
mainli
hmpv
follow
adenoviru
rv
result
children
take
antibiot
hospit
remain
patient
antibiot
case
could
prove
etiolog
agent
bacteria
confirm
virus
found
combin
viru
bacteria
fungi
found
divid
case
accord
prior
antibiot
use
distribut
antibiot
vs
other
respect
p
look
bacteri
isol
prior
antibiot
use
find
signific
differ
regard
mycoplasma
pneumonia
isol
p
although
one
streptococcu
pneumonia
p
mainli
due
standard
guidelin
gp
start
penicillin
antibiot
pneumonia
expect
mycoplasma
isol
older
children
streptococcu
mainli
isol
younger
patient
mean
age
children
bacteri
pneumonia
year
viral
pneumonia
year
combin
viralbacteri
year
fungal
pneumonia
year
p
valu
crp
lower
case
mycoplasma
case
noncompact
infiltr
chang
xray
p
p
almost
children
immun
pneumococc
vaccin
immun
patient
higher
number
viral
lower
number
bacteri
isol
vs
nonimmun
patient
respect
p
differ
streptococcu
pneumonia
isol
vaccin
statu
major
drop
mycoplasma
isol
vaccin
patient
vs
p
patient
asthma
could
identifi
microorgan
found
virus
bacteria
respect
coinfect
found
children
without
asthma
isol
etiolog
agent
coinfect
one
case
viral
pneumonia
bacteri
pneumonia
confirm
respect
p
children
discharg
healthi
mean
day
hospit
stay
mention
patient
sever
complic
requir
surgic
intervent
conclus
futur
could
expect
viral
pneumonia
increas
vaccin
coverag
mayb
reevalu
treatment
guidelin
object
compar
need
pediatr
critic
care
tertiari
children
hospit
diagnosi
communityacquir
pneumonia
cap
hospitalacquir
pneumonia
hap
furthermor
conduct
pilot
studi
evalu
possibl
medic
biomark
associ
longer
pediatr
intens
care
unit
stay
method
observ
retrospect
cohort
analysi
conduct
children
admit
tertiari
children
hospit
diagnosi
cap
hap
patient
demograph
clinic
characterist
comorbid
collect
januari
decemb
follow
prospect
pilot
studi
conduct
children
admit
pediatr
intens
care
unit
picu
due
pneumonia
progress
evalu
clinic
profil
medic
biomark
primari
endpoint
durat
picu
stay
associ
predict
factor
result
total
patient
episod
pneumonia
male
femal
requir
admiss
children
hospit
includ
mean
age
admiss
month
averag
length
stay
day
episod
identifi
cap
episod
hap
patient
cap
significantli
shorter
length
hospit
stay
durat
icu
stay
hap
vs
day
p
vs
day
p
common
comorbid
cap
neurolog
diseas
atopi
histori
among
cap
patient
episod
led
icu
admiss
treatment
cours
common
comorbid
neurolog
diseas
howev
hap
patient
cardiovascular
diseas
common
comorbid
well
requir
picu
care
overal
mortal
rate
mortal
rate
significantli
higher
hap
group
p
pilot
studi
includ
children
diagnosi
pneumonia
picu
jan
dec
neither
progress
ard
mobil
mortal
occur
mean
age
diagnosi
month
averag
number
day
picu
stay
day
median
durat
hospit
stay
day
patient
divid
two
group
picu
stay
day
less
valu
probnp
platelet
crp
ci
patient
picu
stay
day
show
signific
differ
less
day
initi
picu
admiss
p
howev
valu
thorac
fluid
content
tfc
even
tfc
correct
cardiac
output
significantli
differ
two
group
level
sputum
urinari
reveal
trend
decreas
level
diseas
relief
conclus
studi
found
hap
result
significantli
longer
length
hospit
stay
picu
stay
cap
possibl
risk
factor
need
critic
care
associ
neurolog
diseas
cap
heart
diseas
hap
possibl
biomark
probnp
platelet
crp
ci
may
predict
durat
picu
stay
pilot
studi
result
help
understand
risk
pneumonia
children
requir
critic
care
also
provid
chanc
better
intens
respiratori
care
background
pneumonia
lead
caus
respiratori
morbid
mortal
children
younger
year
age
incid
sever
case
communityacquir
pneumonia
cap
lowand
middleincom
countri
still
high
although
sever
cap
diagnos
clinic
featur
chest
xray
could
use
measur
biomark
predict
outcom
aim
studi
determin
associ
method
nineti
children
age
day
year
hospit
diagnosi
sever
cap
pediatr
depart
west
nusa
tenggara
provinc
gener
hospit
januari
octob
enrol
data
demograph
clinic
characterist
laboratori
examin
record
subject
treat
accord
hospit
cap
protocol
prospect
monitor
discharg
result
subject
age
year
male
passiv
smoke
exposur
live
crowd
environ
came
low
famili
incom
show
infiltr
chest
xray
comorbid
fe
defici
anemia
common
creactiv
protein
esr
lc
nlr
significantli
associ
hospit
length
stay
durat
oxygen
consumpt
p
adjust
crp
lc
nlr
age
esr
found
associ
mortal
everi
increas
one
log
esr
decreas
log
odd
death
p
conclus
higher
esr
associ
lower
risk
death
howev
none
biomark
associ
hospit
length
stay
durat
oxygen
consumpt
keyword
communityacquir
pneumonia
outcom
children
biomark
recurr
episod
bronchial
obstruct
enrol
studi
detail
histori
physic
examin
blood
sampl
nasopharyng
aspir
npa
collect
perform
viral
etiolog
respiratori
tract
infect
determin
use
polymeras
chain
reaction
pcr
concentr
npa
elisa
kit
result
mean
npa
level
rsv
infant
pgml
lower
rsv
infant
pgml
p
gender
differ
detect
signific
higher
valu
girl
ci
p
cytokin
ratio
differ
infant
without
atop
statu
famili
histori
asthma
moderatetosever
bronchiol
case
associ
lower
level
ci
p
none
requir
mechan
ventil
decreas
product
correl
recurr
episod
wheez
p
object
test
hypothesi
high
amplitud
bcpap
support
acut
lung
injuri
may
differ
effect
ga
exchang
effici
lung
injuri
protect
compar
high
flow
cpap
mimick
hfnc
support
rat
ali
method
normal
salin
lavag
lung
injuri
rat
initi
receiv
high
tidal
volum
mechan
ventil
mlkg
minut
randomli
divid
three
group
high
amplitud
bcpap
group
use
bubbl
techniqu
degre
expiratori
limb
n
standard
bcpap
group
use
bubbl
techniqu
degre
expiratori
limb
n
high
flow
cpap
mimick
hfnc
group
use
high
flow
techniqu
lmin
n
group
kill
hour
bcpap
high
flow
cpap
mimick
hfnc
support
arteri
blood
gase
respiratori
rate
peak
inspiratori
pressur
pip
mean
airway
pressur
map
rat
lung
respiratori
support
wettodri
lung
weight
ratio
lung
homogen
andor
bronchoalveolar
lavag
fluid
tumor
necrosi
macrophag
inflammatori
total
protein
level
measur
compar
among
group
studi
complet
result
high
amplitud
bcpap
group
exhibit
significantli
higher
lower
significantli
lower
alveolar
protein
pip
map
wettodri
lung
weight
ratio
cytokin
level
compar
high
flow
cpap
mimick
hfnc
group
high
amplitud
bcpap
group
also
exhibit
lower
cytokin
level
compar
standard
bcpap
group
differ
ga
exchang
effici
observ
two
bcpap
group
conclus
high
amplitud
bcpap
support
decreas
lung
inflamm
increas
ga
exchang
effici
lung
complianc
compar
high
flow
cpap
mimick
hfnc
support
rat
ali
may
better
lung
protect
effect
standard
bcpap
keyword
bubbl
continu
posit
airway
pressur
highflow
nasal
cannula
respiratori
support
acut
lung
injuri
nontraumat
chylothorax
children
rare
difficult
treat
traumat
chylothorax
case
refractori
convent
treatment
lead
sever
morbid
mortal
thu
purpos
studi
analyz
clinic
featur
chylothorax
pediatr
patient
hospit
seek
appropri
therapeut
manag
method
retrospect
review
perform
patient
chylothorax
januari
decemb
children
hospit
seoul
nation
univers
traumat
postop
chylothorax
exclud
total
patient
nontraumat
chylothorax
includ
studi
etiolog
treatment
outcom
chylothorax
analyz
result
nontraumat
chylothorax
diagnos
patient
male
patient
frequent
affect
femal
patient
eighteen
patient
diagnos
year
age
two
patient
diagnos
year
age
year
old
year
old
respect
common
caus
spontan
chylothorax
idiopath
factor
constitut
three
case
relat
high
central
venou
pressur
due
venou
thrombosi
recurr
sepsi
case
relat
syndrom
case
noonan
syndrom
remain
case
gorham
stout
syndrom
seventeen
patient
need
respiratori
support
devic
latter
receiv
low
flow
oxygen
supplement
patient
receiv
ventil
support
dietari
modif
npo
mct
base
feed
convent
medic
somatostatin
octreotid
sirolimu
surgic
manag
administr
patient
neonat
infant
group
three
patient
relat
venou
thrombosi
die
recurr
septic
shock
chylothorax
manag
administ
fifteen
patient
receiv
dietari
modif
npo
mct
base
feed
nine
patient
improv
conserv
manag
one
patient
die
due
heart
failur
medic
treatment
somatostatin
octreotid
use
patient
fail
dietari
modif
one
patient
improv
octreotid
among
somatostatin
octreotid
failur
group
patient
receiv
surgic
manag
pleurodesi
thorac
duct
ligat
three
patient
improv
although
one
patient
die
thorac
duct
ligat
oper
postop
ard
two
patient
diagnos
age
refractori
nutrit
modif
convent
medic
somatostatin
octreotid
howev
lymphat
intervent
surgic
treatment
suitabl
two
patient
consid
underli
disord
consist
noonan
syndrom
gorham
stout
syndrom
use
sirolimu
treat
refractori
chylothorax
administr
sirolimu
chylothorax
improv
compar
conclus
nontraumat
spontan
chylothorax
pediatr
patient
occur
newborn
common
caus
chylothorax
neonat
infantil
period
idiopath
hand
nontraumat
chylothorax
childhood
rare
tend
accompani
underli
syndrom
moreov
treatment
failur
rate
higher
childhood
group
case
sirolimu
mtor
inhibitor
benefici
patient
tend
refractori
treat
lymphat
intervent
oper
purpos
specif
genet
caus
childhood
interstiti
lung
diseas
child
immunocompet
patient
identifi
within
past
decad
howev
littl
known
pathogenesi
mani
form
child
treatment
approach
standard
nation
survey
carri
japanes
societi
pediatr
pulmonolog
jspp
identifi
histopatholog
respons
current
treatment
especi
hydroxychloroquin
contraind
children
younger
year
old
japan
method
questionnair
sent
pediatrician
regist
child
patient
jspp
conduct
survey
period
year
children
year
includ
survey
persist
hypoxemia
less
torr
less
week
diffus
infiltr
ct
scan
elev
serum
marker
spa
spd
immunodefici
diseas
present
similar
symptom
child
exclud
questionnair
includ
inform
patient
clinic
symptom
famili
histori
patholog
histolog
clinic
genet
find
treatment
clinic
outcom
inform
consent
obtain
patient
guardian
particip
survey
result
twentysix
case
identifi
includ
male
femal
age
onset
month
year
fourteen
case
present
first
year
life
lung
biopsi
perform
case
five
case
show
chang
nonspecif
interstiti
pneumonia
nsip
case
desquam
interstiti
pneumonia
dip
case
cryptogen
organ
pneumonia
cop
case
usual
interstiti
pneumonia
uip
case
acut
lung
injuri
ali
case
untag
genet
test
perform
case
mutat
spc
gene
sftpc
detect
case
atp
bind
cassett
subfamili
member
case
homeobox
case
coatom
associ
protein
subunit
alpha
case
mutat
detect
case
first
half
studi
period
case
diagnos
genet
test
without
lung
biopsi
increas
case
latter
half
prednisolon
use
case
hydroxychloroquin
case
onset
retinopathi
convent
treatment
prednisolon
hydroxychloroquin
monotherapi
combin
result
good
respons
case
three
children
die
despit
therapi
addit
turn
case
diagnos
juvenil
idiopath
arthriti
year
registr
conclus
first
nationwid
prospect
studi
regard
child
japan
histopatholog
studi
similar
report
previous
increas
emphasi
genet
studi
diagnosi
child
help
avoid
unnecessari
lung
biopsi
corticosteroid
hydroxychloroquin
main
therapeut
agent
studi
hydroxychloroquin
therapi
toler
mani
case
signific
side
effect
method
twenti
three
children
age
year
bo
allogen
hematopoiet
cell
transplant
enrol
clinic
data
review
retrospect
subject
repeat
pulmonari
function
test
interv
month
occurr
result
among
subject
bo
subject
expir
due
respiratori
failur
subject
underw
lung
transplant
subject
need
therapi
mean
valu
predict
diagnosi
bo
rose
month
predict
diagnosi
bo
tend
lower
subject
oxygen
therapi
subject
without
oxygen
therapi
although
statist
signific
chang
predict
month
bo
diagnosi
significantli
lower
subject
oxygen
therapi
subject
without
oxygen
therapi
howev
signific
differ
chang
month
predict
valu
two
group
month
addit
group
neg
slope
predict
chang
first
month
higher
likelihood
therapi
compar
group
posit
slope
chang
period
hr
p
chang
first
month
bo
significantli
differ
subject
without
oxygen
therapi
result
suggest
activ
intervent
strategi
need
first
month
bo
improv
prognosi
studi
aim
assess
effect
hs
nebul
physiotherapi
convent
physiotherapi
children
noncf
bronchiectasi
object
primarili
compar
chang
pretreat
phase
posttreat
phase
two
group
method
perform
retrospect
cohort
studi
extrem
preterm
infant
born
week
gestat
age
nicu
studi
subject
divid
two
group
auto
group
underw
autom
control
inspir
oxygen
concentr
auto
cpap
manual
group
underw
manual
control
inspir
oxygen
concentr
manual
cpap
introduct
auto
nicu
retrospect
investig
patient
characterist
shortterm
outcom
relat
respiratori
system
reintub
rate
durat
cpap
introduct
rate
home
oxygen
therapi
retinopathi
prematur
incid
stage
therapi
rate
mannwhitney
u
test
chisquar
test
use
statist
analysi
logist
regress
use
multivari
analysi
result
total
infant
elig
studi
infant
auto
group
manual
group
respect
auto
manual
group
median
rang
gestat
age
week
p
birth
weight
gram
p
rate
matern
steroid
administr
p
age
studi
entri
day
p
reintub
rate
p
durat
cpap
day
p
introduct
rate
home
oxygen
therapi
p
incid
total
retinopathi
prematur
rop
p
incid
rop
stage
p
therapi
rate
rop
p
group
statist
signific
associ
decreas
risk
rop
stage
use
auto
multivari
analysi
adjust
confound
factor
odd
ratio
ci
p
discuss
studi
incid
rop
stage
significantli
decreas
extrem
preterm
infant
underw
auto
cpap
suggest
exposur
excess
oxygen
level
fluctuat
oxygen
relat
incid
rop
larg
studi
indic
strict
target
rang
fact
manual
control
inspir
oxygen
concentr
respiratori
support
suffici
mainten
within
latter
auto
maintain
within
target
rang
compar
manual
control
inspir
oxygen
concentr
auto
potenti
prevent
rop
decreas
exposur
excess
oxygen
level
fluctuat
oxygen
sever
limit
consid
studi
retrospect
singlecent
nonrandom
studi
multicent
prospect
studi
need
sinc
pulmonari
function
decreas
lower
respiratori
tract
infect
popul
may
sever
clinic
cours
studi
addit
lung
function
measur
also
want
see
whether
connect
mental
abil
pulmonari
function
method
examin
licens
obtain
ethic
committe
univers
szege
conclus
could
also
detect
smaller
popul
vlbw
patient
age
year
lung
function
test
valu
lower
normal
region
refer
rang
may
rais
presumpt
higher
suscept
children
respiratori
tract
diseas
also
later
decad
life
bpd
patient
lower
pulmonari
function
test
result
nonbpd
patient
hand
could
find
connect
low
raven
test
perform
lung
function
result
background
esophag
atresia
ea
andor
tracheoesophag
fistula
tef
one
rare
congenit
anomali
occur
birth
improv
surviv
infant
recent
decad
diagnosi
tef
ea
commonli
made
first
hour
birth
preoper
flexibl
endoscopi
fe
yet
routin
includ
diagnost
postop
assess
studi
aim
evalu
predict
factor
affect
patient
prognosi
role
flexibl
endoscopi
applic
manag
infant
ea
andor
tef
tertiari
medic
center
method
enrol
patient
admit
hospit
due
suspect
ea
andor
tef
accept
fe
examin
one
time
jan
dec
associ
medic
surgic
record
retrospect
review
analyz
data
includ
basic
characterist
diagnosi
age
surgic
repair
associ
anomali
time
fe
surgic
repair
mortal
factor
relat
patient
mortal
analyz
result
total
patient
enrol
includ
case
refer
hospit
mean
birth
weight
gm
includ
lowbirthweight
infant
case
cardiac
anomali
case
age
day
case
underw
fe
reconstruct
common
classif
enrol
case
type
c
addit
airway
anomali
found
case
includ
tracheomalacia
bronchostenosi
lung
hypoplasia
laryng
cleft
one
case
underw
nasaltracheofistulagastr
cathet
insert
surgeri
mean
age
receiv
surgic
reconstruct
day
common
postsurg
complic
anastomot
stenosi
requir
laser
therapi
balloon
dilat
stent
implant
gastroesophag
reflux
also
commonli
found
case
overal
surviv
rate
signific
factor
relat
mortal
postreconstruct
referr
p
age
reconstruct
day
p
cardiovascular
surgeri
requir
p
conclus
infant
ea
andor
tef
fe
feasibl
earli
identif
associ
airway
esophag
anomali
well
postop
diagnosi
therapeut
intervent
postreconstruct
referr
age
reconstruct
day
cardiovascular
surgeri
requir
significantli
relat
mortal
infant
ea
andor
tef
background
patent
ductu
arteriosu
pda
common
cardiovascular
complic
among
prematur
infant
may
respons
prematurityrel
complic
surgic
ligat
consid
medic
treatment
either
fail
contraind
transcathet
occlus
establish
term
infant
recent
appli
prematur
popul
previou
report
state
complic
success
rate
statist
differ
transcathet
techniqu
surgic
ligat
studi
aim
compar
oxygen
statu
oxygen
depend
two
techniqu
basic
demograph
data
chang
pulmonari
score
intub
day
ventilatordepend
day
oxygendepend
day
mortal
within
year
evalu
result
birth
bodi
weight
gestat
age
postmenstru
age
procedur
day
bodi
weight
procedur
day
pulmonari
score
procedur
differ
two
group
rang
bodi
weight
procedur
day
group
group
b
overal
mortal
within
year
similar
p
overal
incid
chronic
lung
diseas
significantli
differ
vs
p
compar
chang
day
procedur
transcathet
closur
group
signific
improv
rare
disord
incid
precis
known
malform
might
threaten
fetu
also
disappear
spontan
neonat
asymptomat
malform
accord
previou
studi
cpam
may
increas
risk
lung
infect
lung
malign
also
argument
use
treat
asymptomat
cpampati
surgeri
purpos
studi
purpos
present
studi
investig
whether
differ
treatment
protocol
nordic
countri
materi
method
questionnair
sent
nordic
center
deal
preand
postnat
manag
patient
congenit
lung
malform
questionnair
aim
collect
inform
preand
postnat
treatment
protocol
center
involv
result
treatment
protocol
malform
vari
larg
nordic
center
prenat
ultrasound
primari
examin
center
magnet
reson
imag
mri
use
routin
next
prenat
examin
four
center
everi
cpampati
persist
find
ultrasound
whole
pregnanc
five
center
use
mri
need
differenti
diagnosi
variou
prenat
intervent
use
case
fetal
hydrop
caus
cpam
shunt
macrocyst
lesion
use
center
matern
cortison
half
center
consult
cooper
center
perform
fetal
surgeri
consid
ex
utero
intrapartum
exit
surgeri
postnat
surgeri
perform
everi
center
symptomat
cpampati
one
center
remov
cpam
instead
perform
followup
asymptomat
patient
four
infant
use
precis
flow
three
use
singl
prong
cannula
tip
mm
remain
infant
use
doubl
prong
infant
cannula
tip
mm
pharyng
pressur
tend
rise
flow
rate
depend
type
cannula
patient
manag
optiflow
junior
mean
pharyng
pressur
flow
rate
lkgmin
prematur
size
cannula
respect
neonat
size
cannula
respect
patient
manag
precis
flow
mean
pharyng
pressur
cannula
flow
rate
lkgmin
singl
prong
cannula
respect
doubl
prong
infant
size
cannula
respect
background
even
though
consid
screen
test
sweat
conduct
sc
analysi
seem
altern
diagnost
method
coulometr
quantit
test
cqt
diagnosi
cystic
fibrosi
cf
wide
accept
coulometri
requir
special
technician
addit
perform
referr
center
hand
sc
sweat
analysi
semiautom
procedur
simpler
faster
convent
cqt
special
poorresourc
set
allow
decentr
diagnost
network
consequ
wider
access
cf
diagnosi
date
studi
compar
two
concomit
conduct
test
perform
patient
object
assess
agreement
two
sweat
conduct
result
perform
concomitantli
young
infant
method
prospect
crosssect
studi
two
sweat
sampl
obtain
two
arm
among
consecut
patient
use
wescor
macroduct
collect
system
conclus
sinc
strength
agreement
perfect
reveal
high
reliabl
sc
apart
role
screen
test
seem
place
diagnost
tool
cf
background
frequent
exacerb
pulmonari
deterior
cystic
fibrosi
cf
radiolog
exposur
chest
xray
ct
scan
frequent
patient
cf
subsequ
potenti
secondari
effect
although
also
requir
lung
ultrasound
abstract
current
use
method
evalu
multipl
diseas
pneumonia
pleural
effus
interstiti
syndrom
pulmonari
fibrosi
therefor
use
lu
cf
would
interest
aim
studi
evalu
thorac
ultrasound
util
cf
exacerb
method
fifti
cf
patient
includ
studi
monitor
year
age
lung
ultrasound
perform
everi
month
clinic
biolog
evalu
ct
scan
perform
exacerb
stabl
patient
everi
year
timet
age
year
ultrasound
perform
use
linear
high
frequenc
mhz
probe
use
score
base
specif
artifact
quantifi
presenc
consolid
interstiti
syndrom
saccular
bronchiectasi
pleural
effus
ct
interpret
use
bhalla
score
system
independ
lu
score
pearson
correl
use
evalu
relationship
lu
score
ct
result
median
ct
bhalla
score
averag
lu
score
consist
moder
morpholog
lung
injuri
good
correl
found
patient
increas
lu
ct
score
r
p
reliabl
correl
lung
ultrasound
score
ct
therefor
valid
luscf
score
r
p
imposs
current
identifi
artifact
patient
acut
exacerb
alveolarinterstiti
syndrom
describ
multipl
bline
artifact
presenc
lake
sign
quantifi
cystic
bronchiectasi
accur
identifi
lu
confirm
ct
method
conduct
retrospect
descript
studi
univers
hospit
montpelli
collect
variou
respiratori
disord
present
followup
children
result
one
hundr
two
file
examin
patient
includ
studi
asthma
concern
patient
cohort
frequent
gener
popul
occitania
region
franc
significantli
relat
atopi
p
respiratori
tract
disord
identifi
patient
common
tracheomalacia
laryngomalacia
lower
respiratori
infect
found
patient
significantli
relat
lymphopenia
p
swallow
disord
p
infant
test
hiv
use
pcr
antibodi
test
associ
hiv
arv
exposur
lung
function
year
assess
use
linear
regress
adjust
bmi
age
zscore
sex
ethnic
socioeconom
statu
se
abstract
quartil
enrol
preand
postnat
smoke
exposur
base
urin
cotinin
result
total
infant
least
one
lung
function
measur
follow
year
heu
male
black
african
ancestri
mother
smoke
pregnanc
household
tobacco
smoke
exposur
nine
hundr
ten
infant
lung
function
test
week
children
year
major
heu
infant
black
african
vs
hu
p
heu
infant
less
household
smoke
exposur
vs
p
lower
se
p
higher
bmi
zscore
year
p
compar
hu
demograph
similar
week
heu
infant
higher
tidal
volum
compar
hu
ci
p
amongst
heu
infant
whose
mother
tripl
therapi
arv
lower
expiratori
flow
ratio
tpteft
compar
whose
mother
zidovudin
azt
ci
p
year
tidal
volum
differ
longer
seen
heu
infant
higher
lung
clearanc
index
compar
hu
ci
p
low
antenat
matern
count
associ
averag
lower
tidal
volum
year
compar
infant
whose
mother
count
cell
ci
p
background
chronic
wet
cough
preval
indigen
children
common
symptom
bronchiectasi
precursor
earli
recognit
chronic
wet
cough
lead
prompt
appropri
treatment
may
potenti
prevent
progress
bronchiectasi
therefor
time
health
seek
chronic
wet
cough
famili
effect
manag
health
practition
potenti
import
prevent
develop
bronchiectasi
purpos
identifi
barrier
enabl
time
health
seek
chronic
wet
cough
famili
optim
manag
health
practition
chronic
wet
cough
aborigin
children
method
qualit
studi
conduct
two
commun
one
remot
town
one
remot
commun
kimberley
region
northern
western
australia
popul
aborigin
data
gather
individu
semistructur
indepth
interview
focu
group
ascertain
key
enabl
describ
provis
cultur
appropri
health
literaci
inform
particip
report
would
seek
help
chronic
wet
cough
inform
could
signifi
underli
diseas
furthermor
famili
suggest
improv
health
practition
knowledg
chronic
wet
cough
databas
complet
monitor
data
air
pollut
co
meteorolog
factor
rel
humid
rainfal
daili
averag
temperatur
collect
environment
protect
agenc
monitor
station
taiwanes
govern
present
studi
er
visit
asthma
ae
defin
case
day
bidirect
control
sampl
weekday
week
er
visit
asthma
defin
control
day
multipl
correl
coeffici
r
multipl
regress
analysi
use
explain
much
varianc
ed
visit
could
explain
given
set
air
pollut
result
studi
case
divid
male
femal
increas
averag
increas
temperatur
associ
asthma
er
visit
conclus
taiwan
asthma
ae
close
relat
low
temperatur
indic
air
pollut
obviou
bia
singl
air
pollut
consid
neglect
influenc
meteorolog
factor
studi
effect
environ
asthma
result
studi
predict
asthma
exacerb
precis
accord
individu
age
gender
local
air
pollut
meteorolog
condit
day
high
risk
asthma
exacerb
patient
asthma
avoiddecreas
outdoor
activ
dress
warmli
maintain
inhal
corticosteroid
therapi
howev
path
length
right
dorsum
manu
statist
signific
signific
differ
complet
time
two
group
reason
consid
left
hand
nondomin
hand
domin
hand
need
kept
clean
touch
asepst
suction
cathet
therefor
novic
particip
unfamiliar
manipul
suction
equip
left
hand
appear
differ
profici
benefit
cg
report
function
virtual
camera
improv
access
aoi
screen
transit
wherea
oper
difficult
could
realiz
effect
learn
advantag
video
describ
easi
concentr
devic
familiar
neg
impress
hard
observ
aoi
compar
cg
signific
differ
group
watch
video
cg
anim
frequenc
distribut
fixat
point
movement
speed
analysi
howev
consid
unignor
potenti
cg
anim
train
tool
conclud
defin
visual
criteria
assess
learn
outcom
digit
content
requir
research
futur
graduat
school
nurs
jikei
univers
school
medicin
tokyo
japan
aim
studi
compar
level
endotrach
suction
profici
expert
novic
use
eyemark
record
headmount
eyetrack
devic
pupil
pupil
lab
usa
use
captur
eye
movement
particip
twelv
experienc
nurs
three
healthcar
facil
year
experi
suction
twelv
nurs
student
univers
experi
provid
suction
real
patient
particip
simul
scenario
patient
endotrach
intub
util
cephalothorax
realia
simul
upper
respiratori
tract
mouth
nose
tracheal
bifurc
repres
biologicalpatholo
show
student
expos
environment
tobacco
smoke
caus
inflamm
respiratori
tract
decreas
lung
function
urinari
cotinin
use
biomark
cigarett
smoke
exposur
object
examin
effect
environment
tobacco
smoke
exposur
urinari
cotinin
level
lung
function
test
children
method
subject
student
age
yearsold
jakarta
data
obtain
questionnair
spirometri
urinari
cotinin
test
use
elisa
method
result
subject
consist
case
group
control
group
urinari
cotinin
level
ngml
found
case
group
control
group
p
ci
signific
differ
urinari
cotinin
level
number
smoker
p
number
cigarett
per
day
p
associ
found
cigarett
smoke
exposur
lung
function
test
signific
differ
school
absente
case
group
control
group
p
ci
conclus
children
expos
environment
tobacco
smoke
rel
littl
data
healthi
children
data
compar
techniqu
children
without
respiratori
diseas
describ
bal
differenti
cellular
count
correl
age
ii
compar
differenti
cytolog
versu
bbal
iqr
howev
adjust
age
use
regress
statist
differ
signific
signific
differ
total
cell
count
nbbal
iqr
versu
bbal
iqr
neutrophil
percentag
nbbal
iqr
versu
bbal
iqr
two
group
signific
differ
differenti
cytolog
age
bbal
nbbal
conclus
nbbal
provid
compar
inform
cellular
compon
bal
compar
bbal
consid
altern
age
influenc
cellular
differenti
count
agematch
data
requir
compar
studi
bal
children
spirometri
assess
children
congenit
heart
diseas
open
heart
surgeri
spirometri
assess
obstruct
type
common
restrict
type
vs
howev
tof
patient
restrict
type
slightli
common
obstruct
type
squeez
squeez
rais
volum
passiv
expir
flowvolum
curv
use
estim
pulmonari
function
infant
background
spirometri
essenti
tool
assess
patient
lung
diseas
howev
necessit
cooper
thu
perform
infant
one
establish
altern
techniqu
infant
raisedvolum
rapid
thoracoabdomin
compress
techniqu
rvtct
use
compress
vest
squeez
chest
forcedli
inflat
lung
near
total
lung
capac
tlc
although
accept
method
far
perfect
sinc
easi
perform
obtain
raisedvolum
passiv
expir
curv
rvpe
passiv
deflat
lung
tlc
easier
techniqu
figur
howev
knowledg
data
obtain
rvpe
curv
assess
abil
estim
expiratori
airway
function
infant
tst
consid
posit
indur
mm
qftgit
howev
anesthet
choic
risk
factor
fever
yet
report
object
aim
studi
explor
role
sed
agent
risk
factor
fever
hour
procedur
addit
risk
factor
investig
well
multivari
analysi
data
comorbid
sedat
choic
age
indic
perform
procedur
bal
perform
find
postprematur
ftt
medic
suggest
sevofluran
young
age
statist
signific
risk
factor
fever
chronic
treatment
montelukast
found
protect
factor
fever
conclud
postbronchoscopi
fever
probabl
inflammatori
noninfecti
process
sevofluran
signific
risk
factor
develop
postbronchoscopi
fever
gener
inflamm
mechan
may
also
explain
montelukst
protect
role
condit
mostli
present
young
children
less
year
old
obes
common
adolesc
treat
patient
allerg
rhiniti
compar
symptom
within
month
pap
trial
significantli
less
patient
complaint
habitu
snore
vs
p
excess
daytim
sleepi
vs
p
signific
improv
psg
paramet
mean
oahi
decreas
tst
tst
p
mean
oxygen
satur
nadir
increas
p
pap
therapi
within
month
follow
patient
adher
pap
satisfactorili
adher
drop
time
latest
followup
satisfactori
usag
establish
month
associ
favor
longterm
outcom
satisfactori
usag
cessat
therapi
due
improv
latest
followup
chi
squar
test
p
commonest
report
reason
nonadher
due
nasal
obstruct
result
fortythre
bemss
place
infant
mean
bw
mean
age
kg
month
respect
stent
locat
trachea
carina
mainstem
bronchi
respect
seven
infant
stent
die
without
obviou
stentrel
mortal
among
stent
children
success
retriev
rigid
endoscopi
placement
diamet
tracheal
bronchial
stent
mm
respect
implant
bemss
could
gradual
significantli
p
expand
end
studi
remain
stent
infant
could
kept
function
diamet
remain
tracheal
remain
bronchial
stent
mm
respect
result
eithti
three
children
includ
male
repres
averag
age
month
rate
ard
mortal
rate
children
syndrom
septic
shock
ard
higher
mortal
rate
septic
shock
without
syndrom
children
syndrom
moder
sever
rang
ventil
tidal
volum
mlkg
averag
peep
medium
case
tidal
volum
mlkg
differ
tidal
volum
peep
survivor
nonsurvivor
case
conclus
ard
high
preval
pediatr
septic
shock
mortal
rate
among
septic
shock
case
syndrom
still
high
accord
unit
polici
transfer
icu
base
idsa
guidelin
patient
need
intens
care
hdu
care
given
patient
requir
supplement
oxygen
maintain
puls
oximetri
analysi
length
hospit
stay
indic
patient
discharg
day
hospit
day
mortal
among
patient
evalu
conclus
retrospect
analysi
reveal
childhood
communityacquir
pneumonia
associ
signific
morbid
econom
burden
major
need
therapi
beyond
first
line
antibiot
may
indic
signific
antibiot
resist
central
sleep
apnea
csa
period
breath
unusu
find
describ
pediatr
patient
congest
heart
failur
howev
csa
report
children
pulmonari
hypertens
herebi
report
girl
idiopath
pulmonari
arteri
hypertens
ipah
frequent
central
event
period
breath
fashion
seen
polysomnographi
normal
follow
medic
treatment
lead
improv
pulmonari
pressur
case
support
import
psg
pediatr
patient
ipah
exclud
osa
potenti
caus
also
assess
presenc
pb
also
show
presenc
pb
might
sign
diseas
sever
marker
respons
present
two
children
tb
endem
region
microbiolog
confirm
tb
present
parapneumon
effus
contain
chyle
misdiagnos
initi
pleural
empyema
tubercul
pleural
effus
occur
chylothorax
uncommon
first
case
girl
present
local
leftsid
chest
pain
parapneumon
effus
previou
liver
transplant
longterm
intraven
cathet
chronic
immunosuppress
therapi
second
case
boy
hivexpos
uninfect
present
report
knowledg
use
gastric
lavag
pcr
diagnos
pjp
report
two
case
p
jirovecii
identifi
gastric
lavag
pcr
treat
appropri
case
preterm
lowbirthweight
male
infant
syndrom
undergon
oper
necrot
enterocol
administ
central
venou
nutrit
start
prednisolon
pericardi
effus
postpericardiotomi
syndrom
month
old
nicu
year
day
onset
pjp
requir
increas
oxygen
level
infiltr
shadow
observ
lung
field
chest
radiographi
glucan
bdg
level
elev
p
jirovecii
detect
gastric
lavag
polymeras
chain
reaction
pcr
trimethoprimsulfamethoxazol
administ
week
follow
condit
improv
case
preterm
verylowbirthweight
male
infant
central
venou
nutrit
digest
tract
diseas
treatment
hydrocortison
month
refractori
hypoglycemia
nicu
day
pjp
onset
show
increas
oxygen
demand
chest
radiographi
show
infiltr
lung
field
bdg
level
elev
p
jirovecii
detect
gastric
lavag
pcr
trimethoprimsulfamethoxazol
administ
week
follow
condit
improv
discuss
immunocompet
children
carri
p
jirovecii
respiratori
tract
percentag
depend
underli
diseas
immunosuppress
patient
therefor
p
jirovecii
detect
import
distinguish
infect
colon
two
case
suspect
pjp
basi
clinic
symptom
background
bdg
level
observ
imag
examin
p
jirovecii
detect
gastric
lavag
pcr
analysi
patient
condit
improv
definit
therapi
knowledg
report
pjp
diagnosi
gastric
lavag
pcr
date
diagnost
techniqu
may
use
difficult
collect
lower
respiratori
tract
specimen
patient
cellular
immunodefici
longterm
steroid
administr
although
prophylact
treatment
trimethoprimsulfamethoxazol
pjp
administ
suggest
necess
prophylaxi
report
boy
previous
hospit
recurr
monthli
pneumonia
sinc
birth
present
region
tertiari
center
pediatr
respira
tracheal
agenesi
ta
extrem
rare
usual
fatal
complet
partial
absenc
trachea
larynx
found
tracheoesophag
fistula
may
exist
usual
prenat
symptom
congenit
anomali
commonli
found
present
lowbirthweight
male
infant
gestat
age
week
birth
weight
born
respiratori
distress
physic
radiolog
examin
disclos
singl
umbil
arteri
bilater
malalign
thumb
sacral
dimpl
hemi
vertebra
difficult
intub
note
soon
birth
transfer
center
intub
endotrach
tube
flexibl
bronchoscopi
perform
found
esophag
intub
blind
pouch
subglott
level
trachea
without
fistula
observ
diagnosi
comput
tomographi
ct
reveal
ta
floyd
type
ii
small
esophagobronchi
eb
fistula
lower
esophagu
link
right
upper
bronchu
age
day
esophag
ligat
gastrostomi
perform
age
day
assist
simul
venoven
extracorpor
membran
oxygen
ecmo
support
cervic
esophagostomi
tracheoplasti
execut
cervic
esophagu
endtoend
anastomos
larynx
divid
excis
eb
fistula
proxim
end
lower
thorac
esophagu
fistula
endtosid
anastomos
right
main
bronchu
distal
end
lower
thorac
esophagu
ligat
howev
pneumothorax
anastomosi
dehisc
repair
narrow
anastomosi
collaps
esophagealconsist
airway
bilater
pulmonari
atelectasi
develop
follow
week
flexibl
bronchoscopi
aid
balloon
dilat
stent
implant
plan
howev
massiv
airleak
mediastinum
peritoneum
shock
dissemin
intravascular
coagul
dic
occur
initi
nasal
cpap
continu
posit
airway
pressur
provid
respiratori
support
howev
intub
final
perform
highfrequ
oscil
use
due
fluctuat
respiratori
condit
seri
chest
plain
film
show
progress
diffus
infiltr
highresolut
comput
tomographi
show
bilater
ground
glass
appear
combin
clinic
featur
imag
present
lung
biopsi
perform
due
high
suspicion
diffus
lung
diseas
oral
steroid
azithromycin
administ
improv
poor
administ
hydroxychloroquin
dehydrogenas
defici
recurr
ventilatorassoci
pneumonia
note
need
sever
type
antibiot
month
age
tracheostomi
perform
lung
transplant
offer
famili
decid
proceed
mechan
ventil
use
due
worsen
clinic
condit
resist
medic
treatment
receiv
palli
extub
full
discuss
famili
month
blood
sampl
collect
genet
test
patient
pass
away
revolution
imag
forgotten
third
circul
improv
understand
lymphat
diseas
pave
way
new
treatment
modal
lymphat
embol
present
girl
kla
whose
pleural
effus
stabil
follow
two
lymphat
embol
procedur
case
report
patient
present
year
recurr
sever
non
pulmonari
infect
chest
radiograph
show
promin
diffus
reticular
opac
despit
absenc
respiratori
symptom
sign
comprehens
immunolog
rheumatolog
investig
normal
exhal
nasal
nitric
oxid
ciliari
biopsi
bronchoscopi
lavag
echocardiographi
oxygen
satur
rest
exert
overnight
chest
ct
show
thicken
interlobular
septa
preserv
parenchym
architectur
bone
scan
show
reduc
uptak
well
left
clavicl
keep
vanish
bone
diseas
effect
osa
caus
ca
although
rapid
maxillari
expans
rme
report
use
object
herein
report
case
patient
osa
like
due
ca
success
treat
rme
night
respiratori
event
index
rei
night
respect
nadir
result
sever
osa
diagnos
sinc
famili
wish
rme
perform
snore
retract
breath
sleep
disappear
week
start
rme
month
later
ocst
perform
two
consecut
night
rei
improv
night
respect
nadir
improv
evid
use
rme
osa
children
establish
howev
rme
use
osa
like
due
moder
ath
ca
patient
suggest
tongu
space
expans
rme
use
therapeut
method
osa
gorhamstout
diseas
also
known
vanish
bone
diseas
rare
diseas
unknown
etiolog
character
progress
osteolysi
prolifer
lymphat
vessel
report
case
gorhamstout
diseas
present
recurr
chylothorax
lytic
bone
lesion
present
femal
infant
fever
cough
vomit
day
transfer
medic
center
due
rapid
progress
pard
within
day
throat
swab
cmv
pcr
test
reveal
posit
chest
radiograph
show
bilater
whiteout
high
ventil
set
requir
maintain
oxygen
cardiac
diseas
exclud
ultrasonographi
intraven
ganciclovir
broadspectrum
antibiot
methylprednisolon
given
ga
exchang
still
poor
oxygen
index
hour
hospit
hfov
appli
map
amplitud
frequenc
time
use
hfov
lung
recruit
set
could
wean
gradual
intraven
immunoglobulin
given
suspect
viral
sepsi
case
report
patient
girl
syndrom
congenit
hypothyroid
small
patent
ductu
arteriosu
anorect
malform
present
persist
fever
cough
week
post
stoma
closur
examin
tachypn
respiratori
rate
breathsminut
subcost
recess
breath
sound
reduc
right
lower
zone
stoni
dull
chest
xray
cxr
show
right
lower
lobe
consolid
locul
parapneumon
effus
minim
thick
stale
bloodstain
fluid
aspir
ultrasound
guid
thoracocentesi
unusu
mass
seen
henc
chest
drainag
abort
contrastenhanc
ct
angiographi
reveal
pulmonari
pseudoaneurysm
within
consolid
lung
adjac
right
pleural
collect
blood
investig
show
drop
hemoglobin
chest
xray
show
extens
right
pleural
effus
ultrasound
describ
right
basal
consolid
pleural
effus
pleural
fluid
sampl
obtain
thoracentesi
purul
exud
characterist
chest
tube
insert
drainag
due
find
thorac
ct
scan
perform
reveal
atelectasi
right
lung
sever
locul
pleural
effus
fluidfil
caviti
right
middl
lower
lobe
sinc
patient
stabl
conserv
manag
prefer
empir
iv
antibiot
cefotaxim
clindamycin
start
day
treatment
pleural
fluid
cultur
posit
miti
miti
sensit
ampicillin
thu
treatment
complet
day
ampicillin
day
cefotaxim
clindamycin
satisfactori
outcom
consid
miti
innocu
commens
organ
oropharynx
skin
gastrointestin
genitourinari
tract
look
primari
infect
site
origin
infect
caviti
third
lower
molar
extend
root
patient
histori
dental
procedur
week
diagnosi
case
report
ninemonthold
male
preterm
bpd
infant
matern
prematur
ruptur
membran
deliv
emerg
caesarean
section
week
gestat
due
fetal
distress
apgar
score
birth
weight
g
respiratori
distress
syndrom
endotrach
intub
perform
patient
transfer
neonat
intens
care
unit
month
mechan
ventil
support
endotrach
tube
remov
patient
treat
niv
support
month
mechan
ventil
support
sinc
birth
decid
make
assess
neurodevelop
patient
brain
mri
conclus
time
preterm
bpd
infant
vd
receiv
niv
support
consid
high
risk
followup
mri
delay
two
reason
need
oral
intub
endotrach
tube
guarante
safeti
respiratori
system
neonat
mriventil
includ
niv
mode
expens
requir
welltrain
respiratori
therapist
oper
mriventil
believ
wellprepar
mriventil
infant
vd
receiv
niv
support
could
undergo
mri
safe
share
case
experi
hope
profess
neonat
respiratori
therapi
could
receiv
attent
present
two
case
diagnos
multipl
consult
case
girl
present
histori
recurr
episod
cyanosi
first
month
life
worsen
respiratori
symptom
poor
exercis
toler
assess
sever
occas
gener
practition
gp
consid
investig
necessari
also
recurr
epistaxi
follow
local
ent
specialist
consid
episod
normal
age
two
admit
local
hospit
lrti
cyanosi
persist
low
oxygen
satur
level
treat
antibiot
given
slow
improv
refer
center
workup
examin
present
failur
thrive
gener
cyanosi
multipl
telangiectasia
oral
caviti
nostril
club
finger
initi
chest
xray
show
abstract
ct
angiographi
reveal
arterioven
malform
avm
middl
segment
right
lower
pulmonari
lobe
multipl
intraparenchym
small
avm
lung
aberr
arteri
descend
aorta
irrig
right
upper
lobe
embol
main
pavm
propos
howev
possibl
due
larg
extens
sinc
embol
devic
accord
size
discuss
sever
intern
forum
thoracotomi
pulmonari
segmentectomi
right
lower
lobe
suggest
perform
month
present
sinc
patient
asymptomat
despit
fact
level
improv
expect
background
children
cystic
fibrosi
cf
frequent
respiratori
exacerb
therefor
occurr
cough
fever
cf
child
rais
suspicion
acut
infecti
event
noncf
child
fevercough
associ
would
suggest
pneumonia
presenc
tachycardia
would
suggest
differ
diagnosi
myocard
hyperthyroid
herein
present
case
girl
cystic
fibrosi
frequent
acut
cough
persist
fever
tachycardia
attack
girl
diagnos
cystic
fibrosi
infanc
pseudobarterr
syndrom
child
evolut
good
good
clinic
biolog
statu
normal
pulmonari
lung
function
describ
normal
lung
clearanc
index
germfre
cough
swab
neg
induc
sputum
monitor
accord
nation
romanian
guidelin
everi
month
region
cf
center
annual
nation
center
clinic
biolog
investig
ct
bronchoalveolar
lavag
perform
age
year
result
evolut
mother
notic
episod
tachycardia
month
actual
admiss
suppos
secondari
play
hospit
anxieti
without
electr
ecg
alter
four
month
admiss
mild
exacerb
associ
insignific
chest
xray
find
receiv
intraven
cephalosporin
month
start
product
cough
fever
rel
strong
persist
despit
ain
first
sixteen
emerg
situat
present
detail
use
format
purpos
obstruct
sleep
apnea
osa
common
disord
estim
schoolag
children
obes
preval
reach
stagger
rate
global
osa
obes
adolesc
estim
fold
higher
lean
peer
pauciti
data
regard
obesityrel
osa
children
year
less
particularli
relev
osa
associ
neurocognit
deficit
aim
studi
evalu
preval
osa
among
obes
toddler
preschool
children
determin
factor
may
associ
presenc
osa
method
retrospect
studi
involv
children
year
identifi
two
canadian
pediatr
tertiari
care
center
inlab
polysomnographi
psg
obes
defin
bmi
percentil
age
gender
zscore
osa
diagnos
obstruct
apneahypopnea
index
oahi
greater
event
per
hour
result
particip
includ
mean
age
year
standard
deviat
sd
mean
bmi
zscore
sd
osa
compar
nonosa
group
osa
group
higher
epworth
sleepi
score
p
like
snore
p
present
studi
compar
studi
nebul
beta
agonist
nebul
adrenalin
ad
advantag
hyperton
salin
bronchiol
undertaken
assess
efficaci
total
number
patient
patient
group
examin
month
age
group
nebul
salbutamol
group
b
nebul
adrenalin
similarli
group
c
nebul
hyperton
salin
comparison
mean
sd
rdai
score
nebul
perform
group
patient
group
ie
b
c
rdai
score
record
time
admiss
ie
minut
minut
minut
nebul
subsequ
day
mean
valu
rdai
score
admiss
discharg
respect
group
group
b
rdai
score
time
admiss
discharg
respect
similarli
group
c
rdai
score
time
admiss
discharg
respect
paramet
treatment
p
valu
signific
minut
time
discharg
p
valu
becam
extrem
signific
mean
differ
hr
rr
rdai
score
assess
subsequ
nebul
group
post
treatment
valu
group
salbutamol
group
b
adrenalin
group
c
hyperton
salin
compar
group
show
increas
hr
group
b
mean
differ
show
increas
trend
group
mean
differ
group
c
mean
differ
p
regard
rr
group
show
decreas
rr
group
b
mean
differ
signific
group
mean
differ
group
c
mean
differ
p
regard
rdai
score
group
show
improv
score
group
b
mean
differ
signific
group
mean
differ
group
c
mean
differ
p
similarli
group
show
improv
group
b
mean
differ
show
improv
group
mean
differ
group
c
mean
differ
p
clinic
paramet
heart
rate
respiratori
rate
rdai
score
group
compar
nebul
nebul
salbutamol
given
group
nebul
adrenalin
group
b
nebul
hyperton
salin
group
c
differ
clinic
paramet
group
compar
subsequ
nebul
mean
respiratori
rate
rdai
score
significantli
improv
group
howev
improv
signific
adrenalin
group
shorter
length
hospit
note
group
c
hyperton
salin
undesir
side
effect
note
group
group
show
transient
increas
heart
rate
although
adrenalin
group
object
endotheli
dysfunct
ed
one
initi
patholog
chang
ultim
lead
atherosclerosi
consequ
cardiovascular
diseas
children
endotheli
dysfunct
higher
risk
develop
system
pulmonari
hypertens
atherosclerosi
cardiac
remodel
potenti
longterm
advers
outcom
adulthood
obstruct
sleep
apnea
syndrom
osa
found
caus
impair
endotheli
function
adult
howev
evid
pediatr
osa
limit
aim
studi
evalu
endotheli
function
larg
cohort
children
clinic
refer
suspect
osa
identifi
risk
factor
contribut
presenc
ed
method
children
age
year
old
habitu
snore
snore
night
per
week
recruit
studi
june
march
subject
underw
overnight
polysomnographi
psg
well
endotheli
function
test
use
peripher
arteri
tonometri
pat
deriv
reactiv
hyperem
index
rhi
subject
divid
osa
primari
snorer
ps
group
accord
obstruct
apneahypopnea
index
oahi
result
total
case
complet
studi
children
diagnos
osa
children
assign
ps
group
differ
age
gender
bmi
zscore
two
group
p
osa
group
lower
rhi
ps
p
univari
correl
analysi
show
rhi
linearli
correl
age
gender
oahi
oxygen
desatur
index
respiratori
relat
arous
index
oxygen
satur
nadir
relationship
bmi
zsore
rhi
quadrat
rhi
bmi
zsore
posit
correl
bmi
zscore
year
followup
regularli
perform
ekg
cardiac
echogram
minut
walk
test
smwt
monitor
serum
bun
bnp
creatinin
also
cardiac
catheter
hemodynam
studi
pet
studi
uptak
glucos
analog
pulmonari
perfusionventil
scan
perform
enrol
six
patient
es
includ
atrial
septal
defect
type
ii
case
atrial
septal
defect
type
right
atrial
isomer
total
cavopulmonari
connect
tcpc
ventricular
septal
defect
male
femal
ratio
hemodynam
studi
reveal
mean
pulmonari
arteri
pressur
mm
hg
pulmonari
vascular
resist
index
wu
except
case
receiv
tcpc
addit
three
case
intrapulmonari
thrombu
right
pulmonari
arteri
three
case
cerebr
stroke
three
case
atrial
fibril
found
lung
scan
reveal
nonspecif
find
note
es
patient
without
intrapulmonari
thrombu
interestingli
increas
uptak
right
ventricl
note
three
case
subsequ
two
mortal
right
ventricular
failur
pediatr
set
correspond
child
weight
tidal
volum
ml
breathsmin
ratio
inspiratori
expiratori
peep
cm
filter
place
endotrach
tube
test
lung
model
smartlung
adult
imt
medic
switzerland
collect
drug
compon
test
drug
deposit
deposit
dose
quantifi
spectrophotometri
measur
perform
five
time
result
percentag
nomin
dose
salbutamol
deposit
filter
adult
model
nebul
aerosol
similar
devic
locat
piec
result
flow
analysi
inhal
pressur
differenti
flow
rate
x
relationship
exhal
pressur
differenti
flow
rate
x
relationship
indic
flow
rate
close
follow
pressur
differenti
n
furthermor
ap
abl
measur
flow
rate
great
stabil
reproduc
experi
result
valv
resist
gener
low
inspiratori
flow
rate
lmin
vari
greatli
differ
valv
rang
howev
flow
rate
increas
variat
reduc
lmin
abil
close
vari
strongli
one
valv
anoth
valv
expiratori
flow
pass
inspiratori
valv
other
partial
close
could
achiev
expiratori
flow
pass
inspiratori
valv
result
confirm
measur
flow
expiratori
valv
maximum
initi
flow
rate
inspiratori
valv
complet
close
tilt
chamber
seem
affect
result
ed
measur
pediatr
breath
paramet
coordin
uncoordin
use
similar
four
custom
vhc
two
vhc
ed
lower
highspe
camera
nac
two
differ
shape
membran
model
use
studi
five
cathet
motion
quiescent
techniqu
piston
techniqu
roll
techniqu
twist
techniqu
dynam
pressur
techniqu
perform
time
weight
secret
measur
digit
scale
neg
pressur
set
suction
time
count
second
oneway
anova
tukey
test
use
analyz
obtain
data
experi
mean
amount
secret
respect
signific
differ
quiescent
techniqu
piston
techniqu
p
piston
techniqu
roll
techniqu
p
flat
membran
model
high
viscou
sputum
highspe
camera
show
absorpt
start
cathet
tip
apertur
two
side
apertur
seal
high
viscou
sputum
dynam
pressur
techniqu
sputum
quickli
absorb
right
research
releas
thumb
bent
suction
cathet
experi
high
viscou
sputum
tracheal
membran
model
mean
secret
weight
respect
signific
differ
five
techniqu
experi
low
viscou
secret
tracheal
membran
model
mean
amount
suction
secret
respect
signific
differ
piston
techniqu
twist
techniqu
p
piston
techniqu
dynam
pressur
techniqu
p
conclus
piston
techniqu
could
absorb
amount
secret
cathet
tip
visibl
flat
membran
model
howev
cathet
motion
suction
secret
dynam
pressur
techniqu
tracheal
model
despit
viscos
secret
even
though
nurs
care
appli
level
neg
pressur
procedur
result
indic
dynam
pressur
techniqu
effect
cathet
motion
remov
secret
tracheal
model
background
respiratori
syncyti
viru
rsv
infect
main
caus
lead
acut
bronchiol
infant
children
less
year
age
children
suscept
rsv
infect
adult
especi
hemodynamicsignific
congenit
heart
diseas
heart
failur
studi
aim
evalu
possibl
risk
factor
lead
prolong
stay
pediatr
intens
care
unit
picu
hospit
stay
chd
children
rsv
infect
method
data
retrospect
retriev
patient
chd
jan
dec
patient
concurr
rsv
infect
underw
comput
tomographi
imag
studi
includ
studi
group
clinic
present
record
classifi
statist
use
descript
analysi
p
taken
signific
result
total
patient
associ
congenit
heart
diseas
includ
mortal
rate
due
pulmonari
edema
dysfunct
cyanosi
total
number
subject
whose
age
year
old
similar
whose
abstract
age
year
old
chd
children
airway
problem
includ
tracheabronchomalacia
stenosi
trachea
bronchu
patient
age
less
year
old
longer
hospit
stay
whose
age
year
old
mean
picu
stay
intub
period
similar
trend
comparison
group
without
airway
anomali
hospit
stay
children
hemodynamicsignific
chd
heart
failur
without
associ
airway
anomali
day
compar
day
children
hemodynamicsignific
chd
heart
failur
without
airway
anomali
p
children
airway
anomali
fulfil
criteria
hemodynamicsignific
chd
heart
failur
longer
hospit
stay
day
without
airway
anomali
hemodynamicsignific
chd
heart
failur
day
p
conclus
patient
airway
anomali
rare
children
chd
although
sever
vari
lower
airway
anomali
associ
longer
hospit
stay
chd
children
hemodynamicsignific
heart
failur
found
airway
problem
risk
factor
prolong
hospit
picu
stay
chd
children
rsv
bronchiol
achiev
success
sustain
outcom
chd
children
rsv
bronchiol
crucial
earli
identif
concomit
airway
anomali
children
